Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Atai Beckley N.V - Common Shares (NQ:ATAI)

4.430 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EST, Nov 11, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,924
Open 4.430
Bid (Size) 4.410 (100)
Ask (Size) 4.480 (1,000)
Prev. Close 4.430
Today's Range 4.430 - 4.430
52wk Range 1.150 - 6.750
Shares Outstanding 166,010,476
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
AtaiBeckley Announces Positive Topline Data from the Phase 2b Open-Label Extension Study of BPL-003, Supporting Safety and Efficacy of a Second Dose in Patients with Treatment-Resistant Depression
From AtaiBeckley N.V.
Via GlobeNewswire
atai Life Sciences and Beckley Psytech Announce the Successful Completion of Their Strategic Combination to Create AtaiBeckley, a Global Leader in Transformative Mental Health Therapies
From AtaiBeckley N.V.
Via GlobeNewswire

Performance

YTD
+176.9%
+176.9%
1 Month
-18.0%
-18.0%
3 Month
+7.3%
+7.3%
6 Month
+214.2%
+214.2%
1 Year
+180.4%
+180.4%

More News

Read More
Analyst Expectations For ATAI Life Sciences's Future
Via Benzinga
atai Life Sciences Announces Closing of Public Offering and Full Exercise of Option to Purchase Additional Common Shares
From atai Life Sciences
Via GlobeNewswire
Why Atai Life Sciences Stock Was So Lively This Week
Via The Motley Fool
atai Life Sciences Announces Pricing of Public Offering of Common Shares
From atai Life Sciences
Via GlobeNewswire
atai Life Sciences Announces Proposed Public Offering of Common Shares
From atai Life Sciences
Via GlobeNewswire
atai Life Sciences and Beckley Psytech Announce U.S. FDA Breakthrough Therapy Designation Granted to BPL-003, Underscoring its Potential in Treatment-Resistant Depression
From atai Life Sciences
Via GlobeNewswire
Market Momentum: A Diverse Group of Stocks Soar to 52-Week Highs Amidst Shifting Tides
Via MarketMinute
Topics Earnings Economy Intellectual Property
Atai Life Sciences Remains Undervalued, Analyst Initiates With Around 125% Stock Upside
Via Benzinga
Alibaba, Lithium Americas And Other Big Stocks Moving Higher In Wednesday's Pre-Market Session
Via Benzinga
Demystifying ATAI Life Sciences: Insights From 5 Analyst Reviews
Via Benzinga
Why Atai Life Sciences Stock Crushed It on Tuesday
Via The Motley Fool
Atai Life Sciences Experimental Depression Drug Shows Sustained Benefit In Treatment-Resistant Patients
Via Benzinga
atai Life Sciences and Beckley Psytech Report Positive Phase 2a Data Demonstrating Improved Outcomes with a Two-Dose Induction Regimen of BPL-003 in Patients with Treatment-Resistant Depression
From atai Life Sciences
Via GlobeNewswire
MissionIRNewsBreaks – Brera Holdings PLC (NASDAQ: BREA) Jumps as ARK Invest Buys $49.7M Stake, Trims Roku and Tempus AI
Via Investor Brand Network
Topics Artificial Intelligence
Cathie Wood's Ark Bets Big On Solana Treasury Play: Makes $162M Investment In Brera Holdings As Stock Explodes 225%
Via Benzinga
Topics Artificial Intelligence
atai Life Sciences Awarded Grant from the National Institutes of Health
From atai Life Sciences
Via GlobeNewswire
atai Life Sciences to Participate in September Investor Conferences
From atai Life Sciences
Via GlobeNewswire
Atai Life Sciences Revenue Jumps 163%
Via The Motley Fool
Topics Intellectual Property
atai Life Sciences Reports Second Quarter 2025 Financial Results and Recent Corporate Updates
From atai Life Sciences
Via GlobeNewswire
This IonQ Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday
Via Benzinga
This Atai Life Sciences Analyst Begins Coverage On A Bullish Note; Here Are Top 4 Initiations For Tuesday
Via Benzinga
Why Is ATAI Life Sciences Stock Trading Lower On Monday?
Via Benzinga
What's going on in today's pre-market session
Via Chartmill

Frequently Asked Questions

Is Atai Beckley N.V - Common Shares publicly traded?
Yes, Atai Beckley N.V - Common Shares is publicly traded.
What exchange does Atai Beckley N.V - Common Shares trade on?
Atai Beckley N.V - Common Shares trades on the Nasdaq Stock Market
What is the ticker symbol for Atai Beckley N.V - Common Shares?
The ticker symbol for Atai Beckley N.V - Common Shares is ATAI on the Nasdaq Stock Market
What is the current price of Atai Beckley N.V - Common Shares?
The current price of Atai Beckley N.V - Common Shares is 4.430
When was Atai Beckley N.V - Common Shares last traded?
The last trade of Atai Beckley N.V - Common Shares was at 11/11/25 04:00 PM ET
What is the market capitalization of Atai Beckley N.V - Common Shares?
The market capitalization of Atai Beckley N.V - Common Shares is 735.43M
How many shares of Atai Beckley N.V - Common Shares are outstanding?
Atai Beckley N.V - Common Shares has 735M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.